BLEOMYCIN DISPOSITION IN CHILDREN WITH CANCER

被引：13

作者：

YEE, GC

CROM, WR

LEE, FH

SMYTH, RD

EVANS, WE

机构：

[1] ST JUDE CHILDRENS RES HOSP,CLIN PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101

[2] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201

来源：

关键词：

D O I：

10.1038/clpt.1983.91

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：668 / 673

页数：6

共 25 条

[1] ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177
[2] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION
BENET, LZ
GALEAZZI, RL
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) : 1071 - 1074
[3] BENNETT WM, 1980, CANCER TREAT REP, V64, P921
[4] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN
BLACHLEY, JD
HILL, JB
[J]. ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) : 628 - 632
[5] BROUGHTON A, 1976, CANCER RES, V36, P1418
[6] BROUGHTON A, 1977, CANCER, V40, P2772, DOI 10.1002/1097-0142(197712)40:6<2772::AID-CNCR2820400603>3.0.CO
[7] 2-1
[8] BURGER RM, 1981, LIFE SCI, V28, P715, DOI 10.1016/0024-3205(81)90153-3
[9] VARIABILITY IN DERIVED PARAMETERS OF FUROSEMIDE PHARMACOKINETICS
CHENNAVASIN, P
JOHNSON, RA
BRATER, DC
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05): : 623 - 633
[10] CROOKE ST, 1977, CANCER TREAT REP, V61, P1631